References
- Case D B, Atlas S A, Laragh J H, Sealey J E, Sullivan P A, McKinstry D N. Clinical experience with blockade of renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients. Prog Cardiovasc Dis 1978; 21: 195–206
- Murthy V S, Waldron T L, Goldberg M E. The mechanism of bradykinin potentiation after inhibition of angiotensin-converting enzyme by SQ 14,225 in conscious rabbits. Circ Res 1978; 43(Suppl I)I-40–I-45
- Carretero O A, Scicli A G. Possible role of kinins in circulatory homeostasis. State of the art review. Hypertension 1981; 3(Suppl I)I-4–I-9
- Nasjletti A, Malik K U. Relationship between the kallkrein-kinin and prostaglandin system. Life Sci 1979; 25: 99–103
- Millar J A, McGrath B P, Matthews P G, Johnston C I. Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients. Clin Sci 1981; 61: 75–83
- Zimmermen B G, Sybertz E J, Wong P G. Interaction between sympathetic and renin-angiotensin system. J Hypertension 1984; 2: 581–587
- Crantz F R, Swartz S L, Hollenberg N K, Moore T J, Dluhy R G, Levine L, Williams G H. Role of prostaglandins in the hypotensive response to captopril in essential hypertension. Clin Res 1979; 27: 592A